Displaying drugs 7751 - 7775 of 7817 in total
VTP-27999
VTP-27999 has been used in trials studying the basic science of Renal Function.
Investigational
Terguride
Experimental
Rocacetrapib
Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).
Investigational
Sakuranetin
Experimental
CRA_10991
Experimental
Myricetin
Experimental
3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE
Experimental
CAP-1
Experimental
Taxifolin
Experimental
1,8-Di-Hydroxy-4-Nitro-Anthraquinone
Experimental
Elcatonin
Experimental
Matched Iupac: … methylpentanamido]acetamido}hexanamido)-4-methylpentanamido]-3-hydroxypropanamido}-4-carbamoylbutanamido)butanoic acid …
Tandutinib
MLN518 is a novel, oral, small molecule designed to inhibit type III receptor tyrosine kinases, including FLT3, (platelet-derived growth-factor receptor) PDGFR and c-KIT. Tyrosine kinases are enzymes involved in several cellular processes and are known to be activated in cancer cells to drive tumor growth. AML patients with FLT3 mutations...
Investigational
Displaying drugs 7751 - 7775 of 7817 in total